These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15571302)

  • 1. [Differential therapy of advanced Parkinson's disease with special reference to complementary therapeutic approaches].
    Ulm G
    Praxis (Bern 1994); 2004 Nov; 93(45):1869-72. PubMed ID: 15571302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coenzyme Q10.
    Med Lett Drugs Ther; 2006 Feb; 48(1229):19-20. PubMed ID: 16498307
    [No Abstract]   [Full Text] [Related]  

  • 3. Coenzyme Q10 in early Parkinson disease.
    Hunter DA
    Arch Neurol; 2003 Aug; 60(8):1170; author reply 1172-3. PubMed ID: 12925382
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of coenzyme Q10 therapy in Parkinson disease could be symptomatic.
    Horstink MW; van Engelen BG
    Arch Neurol; 2003 Aug; 60(8):1170-2; author reply 1172-3. PubMed ID: 12925381
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions.
    Schapira AH; Olanow CW
    JAMA; 2004 Jan; 291(3):358-64. PubMed ID: 14734599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Q10 therapy in patients with idiopathic Parkinson's disease.
    Strijks E; Kremer HP; Horstink MW
    Mol Aspects Med; 1997; 18 Suppl():S237-40. PubMed ID: 9266528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALS lessons learned from other neurological diseases. Parkinson's disease.
    Fahn S
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():26-30. PubMed ID: 15512865
    [No Abstract]   [Full Text] [Related]  

  • 8. Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease.
    Shults CW; Flint Beal M; Song D; Fontaine D
    Exp Neurol; 2004 Aug; 188(2):491-4. PubMed ID: 15246848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future directions in the treatment of Parkinson's disease.
    Schapira AH
    Mov Disord; 2007 Sep; 22 Suppl 17():S385-91. PubMed ID: 18175401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective actions of coenzyme Q10 in Parkinson's disease.
    Sharma S; Kheradpezhou M; Shavali S; El Refaey H; Eken J; Hagen C; Ebadi M
    Methods Enzymol; 2004; 382():488-509. PubMed ID: 15047119
    [No Abstract]   [Full Text] [Related]  

  • 11. Measuring the effects of therapy in Parkinson disease.
    Shults CW; Haas R; Oakes D; Kieburtz K; Plumb S; Shoulson I; Beal MF; Juncos J; Nutt J
    JAMA; 2004 May; 291(20):2430-1; author reply 2431. PubMed ID: 15161889
    [No Abstract]   [Full Text] [Related]  

  • 12. Parkinson's disease: diagnosis and treatment.
    Rao SS; Hofmann LA; Shakil A
    Am Fam Physician; 2006 Dec; 74(12):2046-54. PubMed ID: 17186710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Coenzyme Q10 in Huntington's disease and early Parkinson's disease.
    Beal MF; Shults CW
    Biofactors; 2003; 18(1-4):153-61. PubMed ID: 14695931
    [No Abstract]   [Full Text] [Related]  

  • 14. Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease.
    Müller T; Büttner T; Gholipour AF; Kuhn W
    Neurosci Lett; 2003 May; 341(3):201-4. PubMed ID: 12697283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coenzyme Q10.
    Pepping J
    Am J Health Syst Pharm; 1999 Mar; 56(6):519-21. PubMed ID: 10192685
    [No Abstract]   [Full Text] [Related]  

  • 16. [Parkinson's disease: diagnostic and therapeutic criteria. Short text].
    Neurochirurgie; 2000 Dec; 46(6):549-57. PubMed ID: 11203691
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of alternative pharmacotherapy in management of cardiovascular diseases.
    Chagan L; Ioselovich A; Asherova L; Cheng JW
    Am J Manag Care; 2002 Mar; 8(3):270-85; quiz 286-8. PubMed ID: 11924555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and therapy of idiopathic Parkinson's disease].
    Reichmann H
    MMW Fortschr Med; 2006 May; Spec no. 2():54, 56-8, 60-1. PubMed ID: 20104716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease. Diagnosis and the initiation of therapy.
    Bhat V; Weiner WJ
    Minerva Med; 2005 Jun; 96(3):145-54. PubMed ID: 16175158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurostimulation for Parkinson's disease with early motor complications.
    Schuepbach WM; Rau J; Knudsen K; Volkmann J; Krack P; Timmermann L; Hälbig TD; Hesekamp H; Navarro SM; Meier N; Falk D; Mehdorn M; Paschen S; Maarouf M; Barbe MT; Fink GR; Kupsch A; Gruber D; Schneider GH; Seigneuret E; Kistner A; Chaynes P; Ory-Magne F; Brefel Courbon C; Vesper J; Schnitzler A; Wojtecki L; Houeto JL; Bataille B; Maltête D; Damier P; Raoul S; Sixel-Doering F; Hellwig D; Gharabaghi A; Krüger R; Pinsker MO; Amtage F; Régis JM; Witjas T; Thobois S; Mertens P; Kloss M; Hartmann A; Oertel WH; Post B; Speelman H; Agid Y; Schade-Brittinger C; Deuschl G;
    N Engl J Med; 2013 Feb; 368(7):610-22. PubMed ID: 23406026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.